Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Benjian GaoFengyi YangDongning ZhengShuai HuJie LiuHong LiuYongfa LiuLinXin LiuRui WangYi ZhaoCheng CuiCheng FangJin YangSong SuYunwei HanXiaoli YangBo Li

Published in: Journal of hepatocellular carcinoma (2023)

The triple therapy was superior to the monotherapy regarding OS, PFS, and ORR of advanced HCC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
clinical trial
combination therapy
mesenchymal stem cells
bone marrow
liver metastases
data analysis